Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomegranate blood-enriching syrup versus Shengxuebao mixture for iron deficiency anemia
ChiCTR2500103965Phase 4Completed
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Jun 2025
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of shiliu buxue syrup in iron deficiency anemia (IDA) (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Hemoglobin. Started Jun 2025; status: completed.
02
Drugs
shiliu buxue syrup
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ChiCTR2500103965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103965.